Nyxoah SA
NYXH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001857190
No open-market purchases or sales by Nyxoah SA insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $37.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Nyxoah SA changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 22 | 20 | −2 |
| Shares | 3.01M | 2.86M | −148.6K (−4.9%) |
| Value | $28.1M | $18.1M | −$10.0M (−35.7%) |
New holders (2)
Institutions that held Nyxoah SA at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 50,382 | $317.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 300 | $2.00K | 0.00% |
Sold out (4)
Institutions that held Nyxoah SA at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Allspring Global Investments Holdings, LLC | 127,903 | $1.22M |
| SEI Investments Co | 27,904 | $265.0K |
| Ameriprise Financial Inc | 26,423 | $251.0K |
| Optiver Holding B.V. | 3,444 | $35.0K |